This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shoaf, K.
Right arrow Articles by Hutkins, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shoaf, K.
Right arrow Articles by Hutkins, R. W.

 Previous Article  |  Next Article 

Infection and Immunity, December 2006, p. 6920-6928, Vol. 74, No. 12
0019-9567/06/$08.00+0     doi:10.1128/IAI.01030-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichia coli to Tissue Culture Cells{triangledown}

Kari Shoaf,1 George L. Mulvey,2 Glen D. Armstrong,2 and Robert W. Hutkins1*

Department of Food Science and Technology, University of Nebraska—Lincoln, Lincoln, Nebraska 68583,1 Department of Microbiology and Infectious Diseases, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada2

Received 30 June 2006/ Returned for modification 15 August 2006/ Accepted 29 August 2006

Prebiotic oligosaccharides are thought to provide beneficial effects in the gastrointestinal tract of humans and animals by stimulating growth of selected members of the intestinal microflora. Another means by which prebiotic oligosaccharides may confer health benefits is via their antiadhesive activity. Specifically, these oligosaccharides may directly inhibit infections by enteric pathogens due to their ability to act as structural mimics of the pathogen binding sites that coat the surface of gastrointestinal epithelial cells. In this study, the ability of commercial prebiotics to inhibit attachment of microcolony-forming enteropathogenic Escherichia coli (EPEC) was investigated. The adherence of EPEC strain E2348/69 on HEp-2 and Caco-2 cells, in the presence of fructooligosaccharides, inulin, galactooligosaccharides (GOS), lactulose, and raffinose was determined by cultural enumeration and microscopy. Purified GOS exhibited the greatest adherence inhibition on both HEp-2 and Caco-2 cells, reducing the adherence of EPEC by 65 and 70%, respectively. In addition, the average number of bacteria per microcolony was significantly reduced from 14 to 4 when GOS was present. Adherence inhibition by GOS was dose dependent, reaching a maximum at 16 mg/ml. When GOS was added to adhered EPEC cells, no displacement was observed. The expression of BfpA, a bundle-forming-pilus protein involved in localized adherence, was not affected by GOS, indicating that adherence inhibition was not due to the absence of this adherence factor. In addition, GOS did not affect autoaggregation. These observations suggest that some prebiotic oligosaccharides may have antiadhesive activity and directly inhibit the adherence of pathogens to the host epithelial cell surface.


* Corresponding author. Mailing address: University of Nebraska, Department of Food Science and Technology, 338 FIC, Lincoln, NE 68583-0919. Phone: (402) 472-2820. Fax: (402) 472-1693. E-mail: rhutkins1{at}unl.edu.

{triangledown} Published ahead of print on 18 September 2006.

Editor: F. C. Fang


Infection and Immunity, December 2006, p. 6920-6928, Vol. 74, No. 12
0019-9567/06/$08.00+0     doi:10.1128/IAI.01030-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Searle, L. E. J., Best, A., Nunez, A., Salguero, F. J., Johnson, L., Weyer, U., Dugdale, A. H., Cooley, W. A., Carter, B., Jones, G., Tzortzis, G., Woodward, M. J., La Ragione, R. M. (2009). A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. J Med Microbiol 58: 37-48 [Abstract] [Full Text]  
  • Daddaoua, A., Martinez-Plata, E., Lopez-Posadas, R., Vieites, J. M., Gonzalez, M., Requena, P., Zarzuelo, A., Suarez, M. D., de Medina, F. S., Martinez-Augustin, O. (2007). Active Hexose Correlated Compound Acts as a Prebiotic and Is Antiinflammatory in Rats with Hapten-Induced Colitis. J. Nutr. 137: 1222-1228 [Abstract] [Full Text]